Significant ALDH3A1 upregulation in HCC and hepatocellular adenomas serves as a biomarker of Wnt/β-catenin signaling pathway activation, although no correlation has been found between ALDH3A1 expression and patient prognosis.165, 166. The gene discussed is ALDH3A1; the disease is hepatocellular adenoma.